当前位置: X-MOL 学术Curr. Pharm. Biotechnol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Apigenin Alleviates Renal Fibroblast Activation through AMPK and ERK Signaling Pathways In Vitro.
Current Pharmaceutical Biotechnology ( IF 2.2 ) Pub Date : 2020-08-31 , DOI: 10.2174/1389201021666200320140908
Ningning Li 1 , Zhan Wang 2 , Tao Sun 3 , Yanfei Lei 4 , Xianghua Liu 5 , Zhenzhen Li 6
Affiliation  

Objective: Renal fibrosis is a common pathway leading to the progression of chronic kidney disease. Activated fibroblasts contribute remarkably to the development of renal fibrosis. Although apigenin has been demonstrated to play a protective role from fibrotic diseases, its pharmacological effect on renal fibroblast activation remains largely unknown.

Materials and Methods: Here, we examined the functional role of apigenin in the activation of renal fibroblasts response to transforming growth factor (TGF)-β1 and its potential mechanisms. Cultured renal fibroblasts (NRK-49F) were exposed to apigenin (1, 5, 10 and 20 μM), followed by the stimulation of TGF-β1 (2 ng/mL) for 24 h. The markers of fibroblast activation were determined. In order to confirm the anti-fibrosis effect of apigenin, the expression of fibrosis-associated genes in renal fibroblasts was assessed. As a consequence, apigenin alleviated fibroblast proliferation and fibroblastmyofibroblast differentiation induced by TGF-β1.

Results: Notably, apigenin significantly inhibited the fibrosis-associated genes expression in renal fibroblasts. Moreover, apigenin treatment significantly increased the phosphorylation of AMP-activated protein kinase (AMPK). Apigenin treatment also obviously reduced TGF-β1 induced phosphorylation of ERK1/2 but not Smad2/3, p38 and JNK MAPK in renal fibroblasts.

Conclusion: In a summary, these results indicate that apigenin inhibits renal fibroblast proliferation, differentiation and function by AMPK activation and reduced ERK1/2 phosphorylation, suggesting it could be an attractive therapeutic potential for the treatment of renal fibrosis.



中文翻译:

芹菜素通过体外AMPK和ERK信号传导途径减轻肾成纤维细胞的活化。

目的:肾纤维化是导致慢性肾脏疾病进展的常见途径。活化的成纤维细胞显着促进肾纤维化的发展。尽管芹菜素已被证明对纤维化疾病起保护作用,但其对肾成纤维细胞活化的药理作用仍然未知。

材料和方法:在这里,我们检查了芹菜素在激活肾成纤维细胞对转化生长因子(TGF)-β1的反应中的功能作用及其潜在机制。将培养的肾成纤维细胞(NRK-49F)暴露于芹菜素(1、5、10和20μM),然后刺激TGF-β1(2 ng / mL)24小时。确定了成纤维细胞活化的标志物。为了证实芹菜素的抗纤维化作用,评估了肾成纤维细胞中纤维化相关基因的表达。结果,芹菜素减轻了由TGF-β1诱导的成纤维细胞增殖和成纤维细胞肌成纤维细胞分化。

结果:芹菜素显着抑制肾成纤维细胞中纤维化相关基因的表达。此外,芹菜素处理显着增加了AMP激活的蛋白激酶(AMPK)的磷酸化。芹菜素处理还明显降低了TGF-β1诱导的肾成纤维细胞ERK1 / 2的磷酸化,但不降低Smad2 / 3,p38和JNK MAPK的磷酸化。

结论:综上所述,这些结果表明芹菜素通过AMPK激活抑制肾成纤维细胞的增殖,分化和功能,并减少ERK1 / 2磷酸化,表明其可能具有治疗肾纤维化的诱人治疗潜力。

更新日期:2020-09-21
down
wechat
bug